Brief: Synact Pharma Gets Proceeds Of SEK 80 Million Through Issue
Feb 5 (Reuters) - SynAct Pharma AB SYNACT.TE :
* CARRIES OUT DIRECTED NEW ISSUE AND GETS PROCEEDS OF SEK 80
MILLION THROUGH ISSUE
Source text for Eikon: ID:nWkr9dqZVP
Further company coverage: SYNACT.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587696600;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development